Autogenous Dentin Graft for Alveolar Ridge Preservatio
ARF-PRF
Clinical and Histological Evaluation of the Efficacy of Autogenous Dentin Graft in Extraction Socket Preservation
2 other identifiers
interventional
9
1 country
1
Brief Summary
When a tooth is extracted, the bone around the empty socket naturally shrinks over time, which can make it difficult to place a dental implant later without additional bone-building procedures. This study investigated whether grafting the socket with the patient's own extracted tooth material, processed into a graft (autogenous dentin graft), can help preserve this bone. The study also examined whether adding platelet-rich fibrin (PRF), a concentrate prepared from the patient's own blood that is rich in healing factors, could further improve outcomes. A total of 56 extraction sockets were randomly assigned to one of four treatment approaches: no grafting (natural healing), dentin graft alone, dentin graft combined with PRF, or a freeze-dried bone allograft, which is a commonly used bone substitute for comparison. Four months after treatment, small bone samples were taken from each site at the time of dental implant placement and examined under the microscope to measure how much new bone had formed, along with other markers of healing such as blood vessel formation and a bone-growth protein called BMP-2. The results showed that sockets treated with dentin graft healed at least as well as those treated with the standard bone substitute, and that combining dentin graft with PRF produced the best healing results of all groups tested. These findings suggest that a patient's own extracted tooth, which would otherwise be discarded, may serve as an effective and low-cost graft material for preserving bone after tooth extraction, particularly when combined with PRF.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Dec 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
December 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 15, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 8, 2025
CompletedFirst Submitted
Initial submission to the registry
August 22, 2026
CompletedFirst Posted
Study publicly available on registry
August 27, 2026
CompletedAugust 27, 2026
August 1, 2026
4 months
August 22, 2026
August 25, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Percentage of Newly Formed Bone
Histomorphometric quantification of the percentage of newly formed bone within the grafted extraction socket, assessed on hematoxylin and eosin-stained sections of bone core biopsies obtained at the time of implant placement.
4 months after grafting
Percentage of Connective Tissue Formation
Histomorphometric quantification of the percentage of connective tissue within the bone core biopsy specimens.
4 months after grafting
Vascularization
Histomorphometric assessment of new vessel formation within the bone core biopsy specimens.
4 months after grafting
BMP-2 Immunoexpression (HSCORE)
Semi-quantitative immunohistochemical assessment of bone morphogenetic protein-2 (BMP-2) expression, calculated using the HSCORE method combining staining intensity and percentage of positive cells.
4 months after grafting
Study Arms (4)
Control
NO INTERVENTIONExtraction sockets were left to heal spontaneously without any graft material, based on natural blood clot formation, with no flap surgery performed.
Dentin
EXPERIMENTALExtraction sockets were grafted with autogenous dentin particles obtained from the patient's own extracted tooth, processed using the Smart Dentin Grinder device.
Dentin + PRF
EXPERIMENTALExtraction sockets were grafted with autogenous dentin particles combined with platelet-rich fibrin (PRF) prepared from the patient's own venous blood.
FDBA
ACTIVE COMPARATORExtraction sockets were grafted with a commercial freeze-dried bone allograft (FDBA), used as a standard comparator graft material.
Interventions
Particulate graft material (300-1200 µm) obtained by processing the patient's own extracted tooth using the Smart Dentin Grinder device (KometaBio, Israel), placed into the extraction socket.
Autogenous dentin particles combined with platelet-rich fibrin, prepared by centrifugation of the patient's own venous blood (2700-3000 rpm, 10-12 minutes), placed into the extraction socket.
Commercial freeze-dried bone allograft placed into the extraction socket as a comparator graft material.
Eligibility Criteria
You may qualify if:
- Systemically healthy individuals (ASA I-II)
- Age 18 years or older
- Presence of a tooth requiring extraction, radiographically confirmed to be non-infected
You may not qualify if:
- Presence of acute infection at the extraction site
- Advanced systemic disease
- Use of medications known to affect bone metabolism
- Current smoking or alcohol use
- Anticipated non-compliance with scheduled follow-up visits
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Yıldırım Beyazıt University, Faculty of Dentistry
Ankara, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- Histological and immunohistochemical evaluations, including HSCORE assessment of BMP-2 expression, were performed independently by two blinded observers who were unaware of the group allocation of each specimen. Surgical treatment allocation was not blinded to the operating surgeon or the patient, as the graft materials used (autogenous dentin, dentin combined with platelet-rich fibrin, freeze-dried bone allograft, or no graft) were visually and procedurally distinguishable.
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Department of Oral and Maxillofacial Surgery
Study Record Dates
First Submitted
August 22, 2026
First Posted
August 27, 2026
Study Start
December 15, 2023
Primary Completion
April 15, 2024
Study Completion
December 8, 2025
Last Updated
August 27, 2026
Record last verified: 2026-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared, as this was not specified in the study protocol approved by the institutional ethics committee, and participant consent did not include provisions for external data sharing.